• Clozapine N-oxide (CNO): Redefining Chemogenetic Precisio...

  2025-10-18

  This thought-leadership article investigates Clozapine N-oxide (CNO) as a next-generation chemogenetic actuator, integrating mechanistic insights, translational strategy, and evidence from recent landmark studies. It offers advanced guidance for researchers seeking to modulate neuronal circuits with unprecedented specificity, highlighting CNO’s unique properties, experimental impact, and clinical translational opportunities. By building on existing literature and extending beyond conventional product narratives, this article positions CNO at the vanguard of GPCR signaling research and psychiatric disorder modeling.

• Resazurin Sodium Salt: Mechanistic Innovation and Strateg...

  2025-10-17

  This thought-leadership article presents a comprehensive, mechanistically rich, and strategically actionable perspective on the use of Resazurin sodium salt as a fluorogenic oxidation-reduction indicator in translational research. Integrating recent advances from disease modeling, including cystic fibrosis drug development, and competitive assay landscapes, we deliver evidence-based guidance and a visionary outlook for researchers seeking robust, scalable, and clinically relevant cell viability solutions.

77 records 6/6 page Previous First page 上5页 6